New York, USA, May 03, 2022 (GLOBE NEWSWIRE) -- The Global Cryoablation Devices Market to Witness Robust Expansion at a CAGR of 8.8% During the Study Period (2019-27), Assesses DelveInsight
The Cryoablation Devices market size is anticipated to increase due to the rising prevalence of cancer & cardiac arrhythmia, rising demand for minimally invasive procedures, rising availability of customized probes for cryoablation, and the rising adoption of cryoablation devices by the physicians.
According to the latest report published by DelveInsight, “Cryoablation Devices Market Insight Report,” the global Cryoablation Devices market is expected to witness significant growth owing to an increase in the development and innovation of cryoablation probes. Furthermore, the rising number of artrio ventricular nodal re-entrant tachycardia (AVNRT) procedures for cancer treatment and the rising prevalence of cancer prevalence and cardiac arrhythmia is also a major factor contributing to the growth of the Cryoablation Devices market. This report will provide an in-depth understanding of the Cryoablation Devices market, further benefiting the competitors or stakeholders operating in the Cryoablation Devices market.
Key Takeaways from the Cryoablation Devices Market Report
- As per DelveInsight analysis, North America is anticipated to dominate the global Cryoablation Devices market during the forecast period.
- The leading Cryoablation Devices companies such as Medtronic, CPSI BIOTECH, Coopersurgical Inc., Atricure, Inc., Galil Medical Inc., Bvm Medical Limited, Healthtronics, Inc., SANARUS TECHNOLOGIES, METRUM CRYOFLEX SP, Boston Scientific Corporation, Varian Medical Systems, Inc., Biosense Webster, Adagio Medical, Icecure Medical, and others are currently working in the Cryoablation Devices market.
- On February 21, 2022, Medtronic bagged the US FDA approval for Freezor and Freezor Xtra Cardiac Cryoablation catheters.
- On June 23, 2021, the United States Food and Drug Administration had expanded approval for Medtronic’s Arctic Front family of cardiac cryoablation catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AFib).
- On April 05, 2021, IceCure Medical won the FDA breakthrough device designation for the cryoablation system.
- On November 10, 2021, Medtronic India launched the cryoablation catheter, the Arctic Front Cardiac Cryoablation Catheter system, for the treatment of atrial fibrillation patients.
- Thus, owing to the launch of such devices, there will be a rapid growth observed in the Cryoablation Devices market during the forecast period.
To read more about the latest highlights related to Cryoablation Devices, get the snapshot of the key highlights entailed in the Cryoablation Devices Market Report
Cryoablation Devices
Cryoablation is a procedure that uses extremely cold gas for freezing and destroying abnormal cells or diseased tissues. The cryoablation devices are often used for both skin disorders and cancers. It is a minimally invasive process wherein the device can be placed directly onto the affected site under the skin. The device can be connected to a machine that helps in delivering both nitrogen and argon, which enables the freezing process. In the process of cryoablation, liquid nitrogen or argon gas can be transmitted using a probe, thus creating cold temperatures at the site of the treatment, thereby freezing the internal tumors.
Cryoablation Devices Market Insights
Geographically, the global Cryoablation Devices market is studied for North America, Europe, Asia-Pacific, and Rest of the World. North America currently leads the global Cryoablation Devices market in terms of revenue share and is expected to remain constant during the forecast period. This domination is owing to the rising prevalence of several types of cancers wherein targeted specific treatment is possible and the increasing prevalence of nerve diseases in the region, among other factors.
Furthermore, the rising emphasis on minimally invasive surgery over conventional methods and the rising adoption of the Cryoablation Devices across the North American region will also contribute to the growth of the regional Cryoablation Devices market. Moreover, the presence of key players in the region, the rising adoption of Cryoablation Devices, along with the increase in healthcare expenditure across the region will further provide immense growth opportunities for the Cryoablation Devices market.
To know more about why North America is leading the market growth in the Cryoablation Devices market, get a snapshot of the report Cryoablation Devices Market
Cryoablation Devices Market Dynamics
The Cryoablation Devices market is experiencing increased product demand due to a number of factors. One important factor is the increasing number of cancer patients. As cryoablation devices are used in cancer treatment, the rising prevalence of cancer around the world can be attributed to an increase in demand for cryoablation devices. Furthermore, the growing number of patients suffering from cardiovascular disorders will raise demand for cryoablation devices, resulting in a rise in the overall growth of the Cryoablation Devices market.
However, a scarcity of competent and educated specialists, as well as worries about the safety of cryoablation devices may limit the growth of the Cryoablation Devices market.
Moreover, COVID-9 had a significant impact on the Cryoablation Devices market. The COVID-19 pandemic had a major impact on the Cryoablation Devices shipment. The COVID-19 patients are occupying advanced healthcare facilities across the world, thus resulting in the scarcity of healthcare staff for the treatment of other illnesses. Apart from that, the elective surgical treatments and the supply chain disruptions during the shutdowns also caused a reduction in the number of surgical procedures around the world.
However, considering the post-pandemic situation wherein the lockdown restrictions have been eased and owing to a large number of vaccinations amongst the population and resumed patient visits, it can be anticipated that there will be an increase in the demand for cryoablation devices, leading to an overall increase of the Cryoablation devices market growth.
Get a sneak peek at the Cryoablation Devices market dynamics @ Cryoablation Devices Market Dynamics Analysis
Scope of the Cryoablation Devices Market Report
- Coverage: Global
- Study Period: 2019-2027
- Market Segmentation By Product Type - Tissue Contact Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems, and Tissue Spray Probe Ablators
- Market Segmentation By Application - Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, Lung Cancer, and Cardiac Arrhythmia
- Market Segmentation By End-User - Hospitals, Ambulatory Surgical Centers, and Speciality Clinics
- Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
- Key Cryoablation Devices Companies - Medtronic, CPSI BIOTECH, Coopersurgical Inc., Atricure, Inc., Galil Medical Inc., Bvm Medical Limited, Healthtronics, Inc., SANARUS TECHNOLOGIES, METRUM CRYOFLEX SP, Boston Scientific Corporation, Varian Medical Systems, Inc., Biosense Webster, Adagio Medical, Icecure Medical, among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
DelveInsight Analysis: The Cryoablation Devices market size is expected to grow at a CAGR of 8.8% during the forecast period from 2022 to 2027.
Which MedTech key players in the Cryoablation Devices market are set to emerge as the trendsetter explore @ Cryoablation Devices Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Cryoablation Devices Market |
| 7 | Cryoablation Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how Cryoablation Devices Market will be growing by 2027? Click to get a snapshot of the Cryoablation Devices Market Analysis
Related Reports
Tumor Ablation Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Tumor Ablation companies such as Medtronic, Boston Scientific Corporation, Galil Medical, among others.
Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cancer Therapy companies such as GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, among others.
Cardiac Ablation Devices Market
Cardiac Ablation Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cardiac Ablation Devices companies such as Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, Inc., Auris Health, Inc., Olympus, CONMED Corporation, among others.
Intratumoral Cancer Therapies Market
Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Intratumoral Cancer Therapies companies such as Daiichi Sankyo, Amgen, Idera Pharmaceuticals, among others.
Liquid Biopsy in Cancer Diagnostics Market
Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Liquid Biopsy in Cancer Diagnostics companies such as Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, among others.
Metastatic Breast Cancer Pipeline
Metastatic Breast Cancer Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Metastatic Breast Cancer companies such as Roche, RemeGen, SynCore Biotechnology, among others.
Other Trending Reports
Allergic Rhinoconjunctivitis Market
Aortic Aneurysm Stent Grafts Market
Zollinger-Ellison Syndrome Market
Chronic Myelocytic Leukemia (CML) Market
Malignant Fibrous Histiocytoma Market
Related Healthcare Blogs
Upcoming Oncological Drugs in 2022
Metastatic Castration-Sensitive Prostate Cancer Treatment Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
